| Filed On | Filing |
|---|---|
| 27 Jan 2026 | EFFECT |
| 16 Jan 2026 | F-6 |
| 25 Jul 2023 |
Form 3: Csl Ltd, 10% owner · Tvardi Therapeutics, Inc.
Holds 7,396,770 shares of Common Stock, par value $0.001 per share |
| 17 Jun 2022 | F-6EF |
| 09 Jun 2014 | EFFECT |
| 28 May 2014 | FORM F-6 |
| 04 Aug 2011 | F-6EF |
| 17 Jun 2010 | F-6EF |
| 04 Nov 2008 | F-6EF |
| 15 Oct 2008 | FORM F-6 |
| 22 Dec 2003 | AUTO-GENERATED PAPER DOCUMENT |
Loading...
